A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi.

Decision making Health technology Health technology assessment Institutionalization Malawi Sub-Saharan Africa

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
11 Apr 2023
Historique:
received: 15 11 2021
accepted: 11 03 2023
medline: 13 4 2023
entrez: 11 4 2023
pubmed: 12 4 2023
Statut: epublish

Résumé

The objective of this study was to assess the feasibility and acceptability of institutionalizing Health Technology Assessment (HTA) in Malawi. This study employed a document review and qualitative research methods, to understand the status of HTA in Malawi. This was complemented by a review of the status and nature of HTA institutionalization in selected countries.Qualitative research employed a Focus Group Discussion (FGD ) with 7 participants, and Key Informant Interviews (KIIs) with12 informants selected based on their knowledge and expertise in policy processes related to HTA in Malawi.Data extracted from the literature was organized in Microsoft Excel, categorized according to thematic areas and analyzed using a literature review framework. Qualitative data from KIIs and the FGD was analyzed using a thematic content analysis approach. Some HTA processes exist and are executed through three structures namely: Ministry of Health Senior Management Team, Technical Working Groups, and Pharmacy and Medicines Regulatory Authority (PMRA) with varyingdegrees of effectiveness.The main limitations of current HTA mechanisms include limited evidence use, lack of a standardized framework for technology adoption, donor pressure, lack of resources for the HTA process and technology acquisition, laws and practices that undermine cost-effectiveness considerations. KII and FGD results showed overwhelming demand for strengthening HTA in Malawi, with a stronger preference for strengthening coordination and capacity of existing entities and structures. The study has shown that HTA institutionalization is acceptable and feasible in Malawi. However, the current committee based processes are suboptimal to improve efficiency due to lack of a structured framework. A structured HTA framework has the potential to improve processes in pharmaceuticals and medical technologies decision-making.In the short to medium term, HTA capacity building should focus on generating demand and increasing capacity in cost-effectiveness assessments. Country-specific assessments should precede HTA institutionalization as well as recommendations for new technology adoptions.

Identifiants

pubmed: 37041590
doi: 10.1186/s12913-023-09276-z
pii: 10.1186/s12913-023-09276-z
pmc: PMC10088659
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

353

Informations de copyright

© 2023. The Author(s).

Références

Int J Technol Assess Health Care. 2020 Apr;36(2):173-178
pubmed: 32312340
Int J Technol Assess Health Care. 2020 Jun;36(3):187-190
pubmed: 32398176
BMC Health Serv Res. 2012 Sep 21;12:332
pubmed: 22999574
Int J Technol Assess Health Care. 2019 Jan;35(1):64-68
pubmed: 30938278
Int J Technol Assess Health Care. 2016 Jan;32(3):122-5
pubmed: 27530151
Cad Saude Publica. 2016 Nov 03;32Suppl 2(Suppl 2):e00022315
pubmed: 27828669
F1000Res. 2017 Dec 11;6:2119
pubmed: 29333249
Health Res Policy Syst. 2014 Dec 02;12:66
pubmed: 25466570
Soc Stud Sci. 2016 Feb;46(1):87-111
pubmed: 26983173
Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):859-868
pubmed: 33882762
Int J Technol Assess Health Care. 2018 Jan;34(3):241-247
pubmed: 29888696
Int J Technol Assess Health Care. 2019;35(6):467-473
pubmed: 31190670
Cost Eff Resour Alloc. 2021 Jul 7;19(1):39
pubmed: 34233710
Int J Health Policy Manag. 2021 Nov 01;10(11):670-672
pubmed: 34634892
S Afr Med J. 2011 May;101(5):286-7
pubmed: 21837863

Auteurs

Joseph Mfutso-Bengo (J)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi. mfutsobengo@medcol.mw.
Centre of Bioethics in Eastern and Southern Africa, Blantyre, Malawi. mfutsobengo@medcol.mw.

Faless Jeremiah (F)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Florence Kasende-Chinguwo (F)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Wingston Ng'ambi (W)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Centre of Excellence in Ethics and Governance, Blantyre, Malawi.

Nthanda Nkungula (N)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Isabel Kazanga-Chiumia (I)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Mercy Juma (M)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Marlen Chawani (M)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.
Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi.

Jobiba Chinkhumba (J)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Pakwanja Twea (P)

Ministry of Health, Malawi Government, Lilongwe, Malawi.

Emily Chirwa (E)

Ministry of Health, Malawi Government, Lilongwe, Malawi.

Kate Langwe (K)

Ministry of Health, Malawi Government, Lilongwe, Malawi.

Gerald Manthalu (G)

Ministry of Health, Malawi Government, Lilongwe, Malawi.

Lucky Gift Ngwira (LG)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Dominic Nkhoma (D)

Health Economics and Policy Unit, Department of Health Systems and Policy, Kamuzu University of Health Sciences (KuHes), Private Bag 360, BLANTYRE 3, Lilongwe, Malawi.

Tim Colbourn (T)

University College London, London, United Kingdom.

Paul Revill (P)

Centre for Health Economics, University of York, York, UK.

Mark Sculpher (M)

Centre for Health Economics, University of York, York, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH